News Daily News Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA Michael O'Riordan August 10, 2023
News Daily News FDA: Class I Recall for Left-Sided Impella Pumps Due to TAVI Interaction Caitlin E. Cox July 27, 2023
News Daily News Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes Shelley Wood July 19, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Daily News PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains Shelley Wood June 22, 2023
News Daily News Journal Series Explores How Eroding Abortion Access Impacts the HF Community Todd Neale June 15, 2023
News Daily News One in Six COAPT Patients Had Malnutrition: TEER Helped Regardless Shelley Wood June 12, 2023
News Daily News Monitoring PA Pressures With CardioMEMS May Help LVAD Patients Todd Neale April 27, 2023
News Daily News Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs Shelley Wood March 31, 2023
News Daily News Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data Michael O'Riordan March 29, 2023
News Daily News For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread Michael O'Riordan January 30, 2023
News Daily News New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump Shelley Wood January 25, 2023
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients Caitlin E. Cox December 09, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Daily News US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? Shelley Wood July 15, 2022
News Daily News Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach Michael O'Riordan June 21, 2022